| Transdermal drug delivery: Innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum A Zaid Alkilani, MTC McCrudden, RF Donnelly Pharmaceutics 7 (4), 438-470, 2015 | 970 | 2015 |
| Microneedles for intradermal and transdermal drug delivery TM Tuan-Mahmood, MTC McCrudden, BM Torrisi, E McAlister, ... European Journal of Pharmaceutical Sciences 50 (5), 623-637, 2013 | 425 | 2013 |
| Microneedles: a new frontier in nanomedicine delivery E Larrañeta, MTC McCrudden, AJ Courtenay, RF Donnelly Pharmaceutical research 33, 1055-1073, 2016 | 300 | 2016 |
| Hydrogel-forming microneedles prepared from “super swelling” polymers combined with lyophilised wafers for transdermal drug delivery RF Donnelly, MTC McCrudden, A Zaid Alkilani, E Larrañeta, E McAlister, ... PloS one 9 (10), e111547, 2014 | 297 | 2014 |
| Enhancement strategies for transdermal drug delivery systems: Current trends and applications D Ramadon, MTC McCrudden, AJ Courtenay, RF Donnelly Drug delivery and translational research, 1-34, 2021 | 291 | 2021 |
| Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs MTC McCrudden, AZ Alkilani, CM McCrudden, E McAlister, HO McCarthy, ... Journal of Controlled Release 180, 71-80, 2014 | 235 | 2014 |
| Hydrogel-forming microneedles enhance transdermal delivery of metformin hydrochloride EM Migdadi, AJ Courtenay, IA Tekko, MTC McCrudden, MC Kearney, ... Journal of controlled release 285, 142-151, 2018 | 224 | 2018 |
| Microneedle applications in improving skin appearance MTC McCrudden, E McAlister, AJ Courtenay, P González‐Vázquez, ... Experimental dermatology 24 (8), 561-566, 2015 | 208 | 2015 |
| Hydrogel-forming microneedle arrays exhibit antimicrobial properties: potential for enhanced patient safety RF Donnelly, TRR Singh, AZ Alkilani, MTC McCrudden, S O’Neill, ... International journal of pharmaceutics 451 (1-2), 76-91, 2013 | 180 | 2013 |
| Hydrogel-forming microneedle arrays exhibit antimicrobial properties: potential for enhanced patient safety RF Donnelly, TRR Singh, AZ Alkilani, MTC McCrudden, S O’Neill, ... International journal of pharmaceutics 451 (1-2), 76-91, 2013 | 180 | 2013 |
| The role of microneedles for drug and vaccine delivery HL Quinn, MC Kearney, AJ Courtenay, MTC McCrudden, RF Donnelly Expert opinion on drug delivery 11 (11), 1769-1780, 2014 | 172 | 2014 |
| Transdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis P González-Vázquez, E Larrañeta, MTC McCrudden, C Jarrahian, ... Journal of Controlled Release 265, 30-40, 2017 | 165 | 2017 |
| Hydrogel-forming microneedle arrays can be effectively inserted in skin by self-application: a pilot study centred on pharmacist intervention and a patient information leaflet RF Donnelly, K Moffatt, AZ Alkilani, EM Vicente-Pérez, J Barry, ... Pharmaceutical research 31, 1989-1999, 2014 | 165 | 2014 |
| Solid lipid nanoparticle-based dissolving microneedles: A promising intradermal lymph targeting drug delivery system with potential for enhanced treatment of lymphatic filariasis AD Permana, IA Tekko, MTC McCrudden, QK Anjani, D Ramadon, ... Journal of controlled release 316, 34-52, 2019 | 153 | 2019 |
| Hydrogel-forming microneedle arrays made from light-responsive materials for on-demand transdermal drug delivery JG Hardy, E Larrañeta, RF Donnelly, N McGoldrick, K Migalska, ... Molecular pharmaceutics 13 (3), 907-914, 2016 | 139 | 2016 |
| Considerations in the sterile manufacture of polymeric microneedle arrays MTC McCrudden, AZ Alkilani, AJ Courtenay, CM McCrudden, ... Drug delivery and translational research 5, 3-14, 2015 | 118 | 2015 |
| Hydrogel-forming microneedle arrays as a therapeutic option for transdermal esketamine delivery AJ Courtenay, E McAlister, MTC McCrudden, L Vora, L Steiner, G Levin, ... Journal of controlled release 322, 177-186, 2020 | 112 | 2020 |
| Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or … EM Vicente-Perez, E Larrañeta, MTC McCrudden, A Kissenpfennig, ... European Journal of Pharmaceutics and Biopharmaceutics 117, 400-407, 2017 | 109 | 2017 |
| Dissolving microneedle delivery of nanoparticle-encapsulated antigen elicits efficient cross-priming and Th1 immune responses by murine Langerhans cells M Zaric, O Lyubomska, C Poux, ML Hanna, MT McCrudden, B Malissen, ... Journal of Investigative Dermatology 135 (2), 425-434, 2015 | 96 | 2015 |
| A facile system to evaluate in vitro drug release from dissolving microneedle arrays E Larrañeta, S Stewart, SJ Fallows, LL Birkhäuer, MTC McCrudden, ... International journal of pharmaceutics 497 (1-2), 62-69, 2016 | 92 | 2016 |
